Glutamate modulation by evenamide produces statistically significant and clinically relevant improvement in patients with TRS Read more about Glutamate modulation by evenamide produces statistically significant and clinically relevant improvement in patients with TRS
Success in the mechanism-based development of evenamide for patients with inadequate response or TRS Read more about Success in the mechanism-based development of evenamide for patients with inadequate response or TRS
Evenamide Phase 3 Program: Study 023 (ENIGMA-TRS 1) evaluates the efficacy of add-on glutamate modulation in patients with documented treatment-resistant schizophrenia Read more about Evenamide Phase 3 Program: Study 023 (ENIGMA-TRS 1) evaluates the efficacy of add-on glutamate modulation in patients with documented treatment-resistant schizophrenia
posters presented @ WCBP Berlin (Study design and MoA) Read more about posters presented @ WCBP Berlin (Study design and MoA)
poster presented @ WCBS (Study 008A results) Read more about poster presented @ WCBS (Study 008A results)
Newron presentation @ HCW Neuro Perspectives Conference Read more about Newron presentation @ HCW Neuro Perspectives Conference
